SS-31 Pen HOCL LABS Clinical Phase III trials have

Clinical Phase III trials have demonstrated that bremelanotide significantly improves sexual desire scores and reduces distress associated with low sexual desire in premenopausal women with hypoactive sexual desire disorder (HSDD) compared with placebo

demonstrating its utility in reproductive hormone studies

💡 Promotes fertility and HPG axis balance in men and women

a key component in regenerative studies

and Halal Certified

SS-31 Pen HOCL LABS Clinical Phase III trials haveSS31, also known as Elamipretide, is a mitochondriatargeted tetrapeptide designed to protect and restore mitochondrial function the energyproducing core of human cells. By selectively binding to cardiolipin in the inner mitochondrial membrane, SS31 helps stabilize mitochondrial structure, reduce oxidative stress, and support efficient adenosine triphosphate (ATP) production the primary energy currency of cells. These actions make SS31 a compelling